Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,877 | -71,961 | -51,219 | -31,783 | -46,037 |
| Depreciation Amortization | 5,317 | 3,508 | 2,107 | 939 | 2,354 |
| Accounts receivable | -441 | 273 | 273 | -5,634 | -523 |
| Accounts payable and accrued liabilities | 667 | 597 | 207 | 1,481 | -673 |
| Other Working Capital | -2,357 | 1,713 | -1,160 | -3,502 | -10,507 |
| Other Operating Activity | 18,676 | 15,411 | 13,310 | 18,592 | 3,663 |
| Operating Cash Flow | $-71,015 | $-50,459 | $-36,482 | $-19,907 | $-51,723 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24,666 | -19,137 | -13,219 | -5,082 | -14,263 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,400 |
| Investing Cash Flow | $-24,666 | $-19,137 | $-13,219 | $-5,082 | $-15,663 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 39,550 | 39,550 | 39,550 | 39,550 | N/A |
| Common Stock Issued | 136,446 | 135,625 | 135,564 | 107 | 171 |
| Other Financing Activity | -2,622 | -2,507 | -2,507 | -1,362 | 107,606 |
| Financing Cash Flow | $173,374 | $172,668 | $172,607 | $38,295 | $107,777 |
| Beginning Cash Position | 103,193 | 103,193 | 103,193 | 103,193 | 62,802 |
| End Cash Position | 180,886 | 206,265 | 226,099 | 116,499 | 103,193 |
| Net Cash Flow | $77,693 | $103,072 | $122,906 | $13,306 | $40,391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,015 | -50,459 | -36,482 | -19,907 | -51,723 |
| Capital Expenditure | -24,666 | -19,137 | -13,219 | -5,082 | -14,278 |
| Free Cash Flow | -95,681 | -69,596 | -49,701 | -24,989 | -66,001 |